240 related articles for article (PubMed ID: 23042785)
21. Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor.
Beetch M; Lubecka K; Shen K; Flower K; Harandi-Zadeh S; Suderman M; Flanagan JM; Stefanska B
Mol Nutr Food Res; 2019 Oct; 63(19):e1801386. PubMed ID: 31327173
[TBL] [Abstract][Full Text] [Related]
22. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation and post-transcriptional regulation of DNA methyltransferases in the ovarian carcinomas of the laying hen.
Lee JY; Jeong W; Lim W; Lim CH; Bae SM; Kim J; Bazer FW; Song G
PLoS One; 2013; 8(4):e61658. PubMed ID: 23613894
[TBL] [Abstract][Full Text] [Related]
24. Wilms' tumor protein (-KTS) modulates renin gene transcription.
Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
[TBL] [Abstract][Full Text] [Related]
25. Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways.
Sitaram RT; Degerman S; Ljungberg B; Andersson E; Oji Y; Sugiyama H; Roos G; Li A
Br J Cancer; 2010 Oct; 103(8):1255-62. PubMed ID: 20842112
[TBL] [Abstract][Full Text] [Related]
26. Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice.
Berry RL; Ozdemir DD; Aronow B; Lindström NO; Dudnakova T; Thornburn A; Perry P; Baldock R; Armit C; Joshi A; Jeanpierre C; Shan J; Vainio S; Baily J; Brownstein D; Davies J; Hastie ND; Hohenstein P
Dis Model Mech; 2015 Aug; 8(8):903-17. PubMed ID: 26035382
[TBL] [Abstract][Full Text] [Related]
27. Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor.
Malik K; Salpekar A; Hancock A; Moorwood K; Jackson S; Charles A; Brown KW
Cancer Res; 2000 May; 60(9):2356-60. PubMed ID: 10811108
[TBL] [Abstract][Full Text] [Related]
28. The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo.
Wagner N; Michiels JF; Schedl A; Wagner KD
Oncogene; 2008 Jun; 27(26):3662-72. PubMed ID: 18212735
[TBL] [Abstract][Full Text] [Related]
29. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
[TBL] [Abstract][Full Text] [Related]
30. Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.
Morris MR; Hesson LB; Wagner KJ; Morgan NV; Astuti D; Lees RD; Cooper WN; Lee J; Gentle D; Macdonald F; Kishida T; Grundy R; Yao M; Latif F; Maher ER
Oncogene; 2003 Oct; 22(43):6794-801. PubMed ID: 14555992
[TBL] [Abstract][Full Text] [Related]
31. DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression.
Wang YA; Kamarova Y; Shen KC; Jiang Z; Hahn MJ; Wang Y; Brooks SC
Cancer Biol Ther; 2005 Oct; 4(10):1138-43. PubMed ID: 16131836
[TBL] [Abstract][Full Text] [Related]
32. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
[TBL] [Abstract][Full Text] [Related]
34. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
[TBL] [Abstract][Full Text] [Related]
35. Nucleosomes containing methylated DNA stabilize DNA methyltransferases 3A/3B and ensure faithful epigenetic inheritance.
Sharma S; De Carvalho DD; Jeong S; Jones PA; Liang G
PLoS Genet; 2011 Feb; 7(2):e1001286. PubMed ID: 21304883
[TBL] [Abstract][Full Text] [Related]
36. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
Fraizer GC; Shimamura R; Zhang X; Saunders GF
J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
[TBL] [Abstract][Full Text] [Related]
37. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
38. Expression of WT1 protein in fetal kidneys and Wilms tumors.
Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
[TBL] [Abstract][Full Text] [Related]
39. Physical and functional interaction of DNA methyltransferase 3A with Mbd3 and Brg1 in mouse lymphosarcoma cells.
Datta J; Majumder S; Bai S; Ghoshal K; Kutay H; Smith DS; Crabb JW; Jacob ST
Cancer Res; 2005 Dec; 65(23):10891-900. PubMed ID: 16322236
[TBL] [Abstract][Full Text] [Related]
40. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
